- News Home
24 April 2014 11:45 am ,
Vol. 344 ,
The National Institutes of Health is revising its "two strikes" rule, which allowed researchers only one chance to...
By stabilizing the components of retromers, molecular complexes that act like recycling bins in cells, a recently...
Fossil fuels power modern society by generating heat, but much of that heat is wasted. Semiconductor devices called...
Researchers are gaining insights into what made Supertyphoon Haiyan so powerful and devastating through post-storm...
Millions around the world got a first-hand look at what it was like to be in Tacloban while it was pummeled by...
Major climate data sets have underestimated the rate of global warming in the last 15 years owing largely to poor data...
The tsetse fly is best known as the vector for the trypanosome parasites that cause sleeping sickness and a disease in...
- 24 April 2014 11:45 am , Vol. 344 , #6182
- About Us
Stem Cell Case Has 'Immediate and Devastating' Impact, Says Research Group
3 September 2010 5:13 pm
A broad research coalition has formally weighed in on the stem cell case, urging Chief Judge Royce Lamberth to suspend his injunction last week halting human embryonic stem cell research. Lamberth faces a Tuesday deadline to make his decision after the Department of Justice (DOJ) on 31 August asked for an emergency stay. Late this afternoon, with a long weekend looming, the Coalition for the Advancement of Medical Research (CAMR), an advocacy group that includes about 100 patient organizations, scientific societies, and foundations, filed an 11-page amicus brief hoping to tip the judge in that direction.
The CAMR brief focuses on two elements it says need to be considered in evaluating the injunction: the public interest in the case and the stay’s impact on patients. The coalition argues that if the judge’s injunction halting the research stands, “the result would be an immediate and devastating impact on ongoing research,” in part because researchers “will have no way to know when such activities may resume.” Because it already takes so long to transform basic scientific findings into actual treatments, the delay “inevitably will harm patients,” the coalition argues.
See our complete coverage of this issue.